These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23588313)

  • 1. Biomarkers for smoking cessation.
    Bough KJ; Lerman C; Rose JE; McClernon FJ; Kenny PJ; Tyndale RF; David SP; Stein EA; Uhl GR; Conti DV; Green C; Amur S
    Clin Pharmacol Ther; 2013 Jun; 93(6):526-38. PubMed ID: 23588313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Microengineered Lung Models for Translational Drug Discovery.
    Niemeyer BF; Zhao P; Tuder RM; Benam KH
    SLAS Discov; 2018 Sep; 23(8):777-789. PubMed ID: 29447055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based biomarkers in drug development.
    Miller RA; Spellman DS
    Adv Exp Med Biol; 2014; 806():341-59. PubMed ID: 24952191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery in advanced prostate cancer: translating biology into therapy.
    Yap TA; Smith AD; Ferraldeschi R; Al-Lazikani B; Workman P; de Bono JS
    Nat Rev Drug Discov; 2016 Oct; 15(10):699-718. PubMed ID: 27444228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating therapeutic targets through human genetics.
    Plenge RM; Scolnick EM; Altshuler D
    Nat Rev Drug Discov; 2013 Aug; 12(8):581-94. PubMed ID: 23868113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective.
    Parasrampuria DA; Bandekar R; Puchalski TA
    Drug Discov Today; 2020 Oct; 25(10):1855-1864. PubMed ID: 32693162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.
    Alymani NA; Smith MD; Williams DJ; Petty RD
    Eur J Cancer; 2010 Mar; 46(5):869-79. PubMed ID: 20138504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the development of new medications for cocaine dependence.
    Bough KJ; Amur S; Lao G; Hemby SE; Tannu NS; Kampman KM; Schmitz JM; Martinez D; Merchant KM; Green C; Sharma J; Dougherty AH; Moeller FG
    Neuropsychopharmacology; 2014 Jan; 39(1):202-19. PubMed ID: 23979119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
    Carden CP; Sarker D; Postel-Vinay S; Yap TA; Attard G; Banerji U; Garrett MD; Thomas GV; Workman P; Kaye SB; de Bono JS
    Drug Discov Today; 2010 Feb; 15(3-4):88-97. PubMed ID: 19961955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation treatment: pharmacogenetic assessment.
    Munafò MR; Lerman C; Niaura R; Shields AE; Swan GE
    Curr Opin Mol Ther; 2005 Jun; 7(3):202-8. PubMed ID: 15977416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biomarker is not the end.
    Nohaile M
    Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of biomarkers in drug discovery and development.
    Goodsaid F
    Expert Opin Drug Discov; 2012 Jun; 7(6):457-61. PubMed ID: 22471322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching Targeted Drug Discovery and Development to Healthcare Professionals.
    Fruchter R; Ahmad M; Pillinger M; Galeano C; Cronstein BN; Gold-von Simson G
    Clin Transl Sci; 2018 May; 11(3):277-282. PubMed ID: 29110398
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.